PRIMARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS: A CASE REPORT FROM BACH MAI HOSPITAL
Main Article Content
Abstract
Background: Primary hemophagocytic lymphohistiocytosis (HLH) is a rare inherited disorder associated with a high mortality rate. The disease is characterized by prolonged fever, hepatosplenomegaly, cytopenias, elevated serum ferritin, hypertriglyceridemia, hypofibrinogenemia, and hemophagocytosis in the bone marrow, lymph nodes, or other tissues. Primary HLH comprises two major groups: familial hemophagocytic lymphohistiocytosis (FHL) and HLH associated with inherited immunodeficiency syndromes, including Chediak–Higashi syndrome, Griscelli syndrome type II, and X-linked lymphoproliferative syndrome (XLP). Mutations in UNC13D are responsible for familial hemophagocytic lymphohistiocytosis type 3 (FHL3), which has a broad spectrum of clinical manifestations, ranging from early onset in the neonatal period to adulthood, with common triggering factors including Epstein–Barr virus (EBV), cytomegalovirus (CMV), or other infectious agents.
Case presentation: We report the case of a 17-year-old female patient diagnosed with primary HLH, presenting with prolonged fever, severe liver injury, and polyserositis, in whom no infectious, autoimmune, or malignant cause was identified. Next-generation sequencing detected two compound heterozygous variants in the UNC13D gene (c.1447-2A>G and c.3151G>A), inherited from her father and mother, respectively, supporting the diagnosis of FHL3. The patient achieved remission after treatment according to the HLH-2004 protocol and is planned to undergo allogeneic hematopoietic stem cell transplantation.
Conclusion: Genetic screening of the patient's family identified heterozygous carriers, contributing to genetic counseling and long-term follow-up planning.
Keywords
hemophagocytic lymphohistiocytosis, UNC13D, familial hemophagocytic lymphohistiocytosis, case report